MSR87 Using Regression Discontinuity in Time Design for Real-World Comparative Effectiveness: A Case Study for the Second-Line Use of Pembrolizumab in Advanced Non-Small Cell Lung Cancer
Abstract
Authors
Nai-Chia Chen Antal T. Zemplenyi Blythe Adamson Cindy L. OBryant Robert B. McQueen Kelly Anderson